 |
 |
| |
|
|
|
2009 Awards |
|
Jennifer DeLuca
Assistant Professor, Colorado State University
The Role of Nuf2 in Chromosome Segregation and Aneuploidy
Prevention |
$30,000 |
Marileila Varella Garcia
Director, University of Colorado Denver Student Cancer Research
Fellowship Program
Student Cancer Research Fellowship Program |
$30,000 |
James Hagman
Associate Professor, National Jewish
Health Causes & Consequences of Leukemogenesis in B Cells |
$30,000 |
Ke-Jun Han
Post Doctoral Fellow, University of Colorado, Denver
Investigate a novel cullin-based E3 ligase-implications in
cancer development |
$30,000 |
Antonio Jimeno
Assistant Professor of Medicine/Oncology University of CO,
Denver
Dual Compartment Strategy w/ Induction Chemotherapy & Hedgehog
Inhibition |
$30,000 |
Tatiana Kutateladze
Assistant Professor University of Colorado, Denver
Molecular Mechanism of Histone Targeting by MLL |
$30,000 |
James Lambert
Assistant Professor, University of Colorado, Denver
The role of prostate derived factor in inhibition of
inflammatory signaling in prostate cells |
$15,000 |
Shi-Long Lu
Assistant Professor, University of Colorado, Denver
Role of AKT in Head and Neck Squamous Cell Carcinomas |
$30,000 |
Eduardo Pajon Jr
Colorado Cancer Research Program
Community Clinical Trials Program |
$30,000 |
Lisa Reaves
Oncology Fellow, University of Colorado, Denver
Pediatric Hematology
The Role of Six1 Homeoprotein in Ewing's Sarcoma Family/Tumors
|
$30,000 |
Jennifer Richer
Assistant Professor University of
Colorado, Denver
A MicroRNA-based Strategy to Reduce Ovarian Cancer
Aggressiveness & Enhance Chemosensitivity |
$30,000 |
John Tentler
Assistant Professor, University of Colorado, Denver
Division of Medical Oncology
Upregulation of the Non-canonical WNT signaling pathway predicts
sensitivity to MEK Kinase Inhibitor |
$30,000 |
Andrew Thorburn
Professor & Vice Chair, University of Colorado, Denver
Department of Pharmacology
Autophagy Manipulation in Brain Tumor Treatment |
$30,000 |
Allen Edward Waziri
University of Colorado, Denver
Department of Neurosurgery
Increased levels of intratumoral adenosine are responsible for
generating myeloid supressor cells in GBM that act to limit the
antitumor cellular immune response. |
$30,000 |
Christian Young
Postdoctoral Fellow, University of Colorado, Denver
Pathology Department
Targeting Glucose Metabolism in Breast Cancer |
$30,000 |
|
|
|
|
2008 Awards |
|
Shideng Bao, Ph.D.
UCDHSC
Targeting glioma cancer stem cells through CD171 to overcome
radioresistance |
$30,000 |
Donald Bellgrau, Ph.D
UCDHSC
Organ specific targeting of immune responses to tumors |
$30,000 |
Lius Pessoa-Brandao, Ph.D.
UCDHSC
Analysis of MerTK contribution to initiation of leukemogenesis |
$30,000 |
Jeannette E. Davies, Ph.D.
UCDHSC
Decorin regulation of glioma invasion & proteoglycan expression |
$29,760 |
Joaquin M. Espinosa
UC at Boulder
Mechanisms of cell fate choice upon therapeutic
activation of p53 |
$30,000 |
Elan Eisenmesser, Ph.D
UCDHSC
Understanding the dual role in cancer progression of the CD147
cellular receptor |
$30,000 |
Thomas W. Flaig, M.D.
UCDHSC
In vivo validation of DAB389EGF for the treatment of
bladder cancer |
$29,650 |
Barbara A. Frederick, Ph.D.
UCDHSC
Serum Biomarkers to Determine Radiotherapy Response
of Patients with Glioblastoma Multiforme |
$21,000 |
Marileila Varella Garcia, Ph.D.
UCDHSC
Student Cancer Research Fellowship Program |
$30,000 |
Kirk C. Hansen, Ph.D
UCDHSC
Proteomic identification of Tumor-associated Extracellular
Matrix |
$30,000 |
Cheng J. Hu, Ph.D.
UCDHSC
Distinct Role of HIF1a and HIF2a in Tumor Progression |
$30,000 |
Ritsuko Iwanaga, Ph.D
UCDHSC
Role of Six1 in maintaining mammary stem cells |
$30,000 |
Tatiana G. Kutateladze, Ph.D.
UCDHSCStructure and function of CHD4 PHD fingers
|
$30,000 |
Mary Reyland, Ph.D.
UCDHSC
Role of PKCdelta in lymphomagenesis |
$30,000 |
Mara Stewart, Ph.D.
UC at BoulderAn in vivo screen for radiation sensitizers in
Drosophila |
$30,000 |
Jessica Tyler, Ph.D
UCDHSC
Discovering the Mechanistic Basis for the Epigenetic Inheritance
of Transcriptional Activity |
$30,000 |
Michael Wang, M.D.
UCDHSC
Polyoma virus infection and human malignancy |
$30,000 |
Trevor Williams, Ph.D.
UCDHSC
The role of the AP-2 gene family in breast cancer |
$30,000 |
Hang Yin, Ph.D. and Jennifer M. Martin,
Ph.D.
UC at Boulder
Multidisciplinary Approaches to Investigate EBV Activation
(Collaborative Project) |
$59,583 |
Rui Zhao, Ph.D.
UCDHSC
Identify small molecule inhibitors of the Six 1 transcriptional
complexes using high throughput screening |
$30,000 |
|
|
|
|
2007 Awards |
|
Aftab Ahmad, Ph.D.
National Jewish
Mechanisma by shich HIF-2α promotes angiogenesis and
tumorigenesis |
$30,000 |
David Bentley, Ph.D.
UCDHSC
A new chromatin modifying enzyme, the JARID1B lysine demthylase
and its targets in breast cancer cells |
$29,000 |
Dawn Duval, Ph.D.
CSU
Ets Transcription Factors in the Development of Hormone
Refractory Breast Cancer |
$30,000 |
Heide Ford, Ph.D.
UCDHSC
Lymphangiogenesis as a Mechanism of Six1-induced Metastasis
|
$30,000 |
Mark Gregory, Ph.D.
UCDHSC
Targeting Wnt Pathway Components in James DeGregori, Ph.D.
Combinationwith Bcr-Abl Inhibition for the Treatment of
Chronic Myeloid Leukemia |
$29,680 |
Fred Hirsch, Ph.D., M.D.
UCDHSC
Characterization of Molecular Abnormalities of
Insulin-like Growth Factor Signaling Pathway in Lung Cancer |
$28,920 |
Mara Miller, Ph.D.
CSU
Acetylation-dependent trascriptional control by the
HTLV-1-encoded oncoprotien Tax |
$30,000 |
Marileila Varella Garcia, Ph.D.
UCDHSC
Student Cancer Research Fellowship Program |
$25,000 |
|
|
|
2006 Awards |
|
Conrado Stoldt
University of Colorado At Boulder
Molecular Imaging of CA-125 Expression in Ovarian
Carcinoma Cells |
$23,965 |
|
Changwei Liu
UCDHSC
Mechanistic studies of polyubiquitlynation chains in protein
degradation, providing potential therapeutic strategies
for multiple cancers |
$30,000 |
|
Mair E. A. Churchill
UCDHSC
Defining the role of the C-terminus of the Histone
Chaperone ASF-1 in Chromatin Assembly |
$29,696 |
|
Richard F.
Bakemeier
UCDHSC
Student Cancer Research Fellowship Program |
$22,000 |
|
Lynn E. Heasley
UCDHSC
FGF Auatocrine Signalling in Gefitinib- Resistant NSCLC |
$30,000 |
|
Kelly Sawczyn
UCDHSC
Mer Expression in E2A-PBX1 Expressing B-cell Acute Lymphoblastic
Leukemia |
$30,000 |
|
Dylan Taatjes
University of Colorado At Boulder
Function of TRRAP/GCN5 in regulating the p53 tumor suppressor |
$30,000 |
|
Rui Zhao
UCDHSC
Targeting the two-component system to control bacterial
infection in cancer patients |
$10,000 |
|
William P.
Schiemann
National Jewish Medical & Research Center
Mechanisms by which MAGP-2 promotes angiogenesis and
tumorigenesis |
$30,000 |
|
Steven Dow
CSU
Role of Phosphatidylsserine Expression in Regulation MCP-1and
VEGF Production by Tumor Cells and Tumor Associated Macrophages |
$30,000 |
|
Douglas H. Thamm
CSU Animal Cancer Center
Mesenchymal Stem Cells for Cancer Gene Delivery: Pilot Study in
Canine Lung Tumors |
$29,890
|
Linda F. van Dyk
UCDHSC
Molecular regulation of a viral cyclin required for
gammaherpesvirus tumorigenesis |
$30,000 |
|
Glen J. Weiss
UCDHSC
Advance Brochioloalveolar Carcinoma of the Lung: Clinical
Parameters and Gene Expression Signatures that may ID patients
for lung Transplantation |
$29,000 |
|
Brian Parr
UCDHSC
Analysis of erbin as a potential tumor suppressor gene |
$30,000 |
|
|
|
|
2005 Awards |
|
Bruce
Banfield, Ph.D., UCDHSC
Targeting Herpesvirus Infection to B-cell Lymphoma |
$30,000 |
Laurent Gapin, Ph.D., UCDHSC
The
role of T-bet in developing lymphocytes |
$30,000 |
Lia Gore, M.D. and Deborah DeRyckere, Ph.D. UCDHSC
Pre-clinical Characterization of Histone DeacetylaseInhibitor
Anti-tumor Activity Using In Vitro and in Vivo Models of
Pediatric Acute Lymphoblastic Leukemia |
$26,500
|
Douglas
K. Graham, M.D., Ph.D., UCDHSC
Ther Mer tyrosine kinase as a potential therapeutic target in
lymphoblastic leukemias |
$30,000 |
Paul Laybourn, CSU
Mechanism of Histone Gene Expression by HTLV-I Tax |
$29,878 |
Christopher Porter, M.D.
and James DeGregori, Ph.D, UCDHSC
Modeling therapy related acute myelogenous leukemia |
$29,132
|
Yosef
Refaeli, Ph.D.
National Jewish Medical and Research Center
Contributions of IKKgamma (NEMO) in the Ligand-independent
component of BCR signals in homeostasis and neoplasia |
$30,000 |
Jennifer Richer, Ph.D, UCDHSC
The
Role of SDF-1 in Estrogen-dependent Breast Cancer Growth |
$30,000 |
John M. Routes, M.D.,
National Jewish Medical and Research Center
Induction of Tumor Specific Immunity Using E1A |
$30,000 |
K. S.
Shailaja, M.D.
and Pepper Schedin, Ph.D, UCDHSC
Identification of the extra cellular matrix proteome responsible
for breast cancer metastasis |
$26,500 |
Jill E.
Slansky, Ph.D, UCDHSC
Consequences of a hypoxic environment on tumors infiltrating
lymphocytes |
$30,000 |
Raul M.
Torres, UCDHSC
Lsc Regulation of cell adhesion in tumor metastasis |
$26,500 |
Rui Zhao, UCDHSC
Structure-Function Analyses of the Six1 Transcriptional Complex
in Breast Cancer
|
$30,000 |
|
|
|
|
2004 Awards: |
|
Jeffrey S.
Kieft, Ph.D. UCHSC
RNA structure-dependent regulation of a virus associated with
Liver Cancer. |
$15,810 |
William P. Schiemann, Ph.D. National Jewish Medical Center
Use
of Cystatin C to Combat Mammary Tumorigenesis Stimulated by TGF-B |
$30,000 |
Sun-Young Han, Ph.D,
UCHSC
Role of
JNK MAPKs in Mouse Lung Tumorigenesis |
$30,000 |
Roberta Pelanda, Ph.D,
National Jewish Medical Center
Molecular
mechanisms of leukemogenesis |
$30,000 |
Kian Behbakht, M.D, UCHSC
Homeobox gene SIX1 over-expression and modulation of Cellular
Retinoic Acid Binding Protein-II(CRABP-II) in Ovarian Cancer |
$30,000 |
Brooks M. Hybertson, Ph.D. Webb-Waring Institute, UCHSC
Beneficial effects of inhaled tocopheryl succinate aerosols in
Lung Cancer |
$30,000 |
Dahai Gai, Ph.D, UCHSC
Study of the Structure-Function Relationship of Simian Virus 40
(SV40) Large Tumor antigen |
$30,000 |
Carla Van
Den Berg, Pharm.D,
UCHSC
Characterization of caspase-9 resistance in Breast Cancer Cells |
$30,000 |
Britta M. Jacobsen, Ph.D, UCHSC
Role of Progesterone Receptor Ratio in Breast Cancer Cells |
$30,000 |
Samir Witta, M.D. UCHSC
Improvement of Response to EGFR Inhibitors in Non-small Cell
Lung Cancer |
$30,000 |
Tatiana G. Kutateladze, Ph.D, UCHSC
Structural basis of signaling by RUFY1 |
$30,000 |
Diego A.R. Zorio, Ph.D, UCHSC
A
novel way of generating gene expression profiles in cancer cells
|
$30,000 |
| |
|
|
2003 Awards: |
|
|
Virginia
F.
Borges,
M.D.
Ass’t Professor of Medicine UCHSC
Stimulation of immune response on human breast cancer by a novel
vaccine-a pilot study. |
$27,470 |
G.S. Capelluto, Ph.D.
Pharmacology UCHSC
Defining the Molecular basis of Prickle interactions in the Wnt
signaling pathway. |
$29,500 |
|
Richard
Coletta, D.D.S. Fellow, UCHSC
Heide Ford, Ph.D. UCHSC
The effect of Breast Cancer associated w/six 1 homebox gene on
cellar proliferation via induction of cyclin A 1 |
$28,777 |
|
Arthur
Gutierrez-Hartman, Director Medical Scientist Training Program,
Professor
Biological function of ETS transcription factors in mammalian lung
tumorigeneis |
$19,000 |
|
Jian Huang, Fellow, UCHSC Trevor William, Associate Professor,
Mentor UCHSC
The role of AP-2 Beta Breast Cancer |
$30,000 |
|
Joseph J. Lucas, Ph.D., Staff Scientist/Assoc. Professor National
Jewish Medical & Research Center
Function of p57KIP2, a protein deficient in T and B cell cancers |
$30,000 |
|
Jennifer Richer, M.D, Ass’t Professor Div. of Endocrinology
Role of ZEB 1 in Normal Mammary Gland Development & Breast Cancer |
$30,000 |
|
Robert Sclafani, Ph.D, Professor, UCHSC
Mechanism of Tobacco-Induced Mutagenesis in Oral Cancers |
$30,000 |
|
Juan Sun
M.D. Post Doctoral Fellow
AMC Research Center
Jaimie Modiano V.M.D.,
Ph.D. Scientist
Center for Cancer Causation and Prevention
Fas ligand based gene therapy |
$30,104 |
Angela
Trobaugh-Lotraio
Pediatric Hematology/Oncology
Fellow Physician, UCHSC & The Children’s Hospital
James
Degregori,
Assistant Professor, UCHSC
The
Role of decreased ASFL-B expression in abnormal S phase
progression, altered hematopoiesis and increased tumorigenesis in
E2F1/E2F2-mutant mice.
|
$30,000 |
| |
|
2002 Awards: |
|
Michele Basche, M.D. UCHSC
An age-stratified phase I clinical trial of the combination
capecitabinem, ZD 1839, and oxaliplatin in patients with advanced
solid tumors |
$29,960. |
Neehar Bhatia, Ph.D. AMC
Analysis for Beta-catenin/Tcf Signaling in Skin Carcinogenesis |
$23,682. |
Andrew P. Bradford, Ph.D. and
Twila Jackson, Ph.D. UCHSC
FGF Regulation of Cell Proliferation in Pituitary Cancer:
Role of Id2 |
$23,682. |
Lin Qi, Ph.D. UCHSC
EGF-PAP Fusion Protein to Target Prostate Cancer |
$29,560. |
Peter McSweeney, M.D.
UCHSC
Vaccination with Mutated VHL Genes as a Treatment for Renal Cell
Carcinoma |
$28,060. |
John Routes, M.D. and Tanya
Miura, Ph.D., M.D. NJMRC
The Role of Lipid Rafts in Signaling by TNF-related
Apoptosis-inducing Ligand |
$30,000. |
Jill Slansky, Ph.D. UCHSC
Binding Properties of T cells Responding to Tumors |
$30,000. |
Harriet Watkin, Ph.D.
UCHSC
Mammary Gland Development & Signaling in Mice lacking Akt1 |
$20,055. |
| |
|
2001 Awards: |
|
Thomas E. Allen, Ph.D. CSU
Investigation of the Pathogenesis of a Retrovirus
Induced Lung Cancer in a Transgenic Mouse |
$30,102. |
Anne Brauweiler, Ph.D. and John
C. Cambier, Ph.D. National Jewish The Role of
Interferon-Gamma in
Macrophage Meditated ADCC |
$30,000. |
Dawn R. Clark, Ph.D.
National Jewish
B and NK Cell Lineage Decisions |
$30,000. |
Bruce D. Cuevas, Ph.D.
UCHSC
Induced Breast Tumorigenesis and Metastasis
Defining the Role of MEKK1 in Oncogene |
$30,000. |
Zonghan Dai, Ph.D. UCHSC
The Role Rac Signal Transduction in Bcr-Abl-Induced Leukemogenesis
|
$30,000. |
S. Gail Eckhardt, M.D.
UCHSC
Correlative and Biological Studies of the Integrin Antagonist, EMD
121974 |
$31,280. |
Gongyi, Zhang, Ph.D.
National Jewish
Domain characterization and Crystallization of Polo-Box
Domain, Kinase Domain and Entire Kinase of P1x1 |
$30,000. |
Daniel L. Gustafson, Ph.D.
UCHSC
Antiangiogenic Scheduling of CPT-11 |
$29,890. |
William P. Schiemann, Ph.D.
National Jewish
Induction of SPARC by TGF-Beta: Effects on Tumor Growth
and Metastasis |
$30,000. |
|
Julie
Flieitz, M.D. and Robert Garcea, M.D. UCHSC and
The Childrens Hospital
Prospective Study of the Association Between Polyomaviruses
(JCV, BKVmSV40) and Pediatric Neuroblastomas and Brain Tumors
|
$29,966. |
|
|
|
|
|
|
